DR. STEVEN WAYNE SUKIN M.D. NPI 1154309516

NPI Details

DR. Steven Wayne Sukin, M.D. is an urology in Tomball, TX with 30 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. DR. Steven Wayne Sukin, M.D. NPI is 1154309516. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: TUFTS UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1996

The provider's business location address is:

506 GRAHAM DR
STE 150
TOMBALL, TX
ZIP 77375-366
Phone: (281) 351-5174
Fax: (281) 351-5172

The NPI 1154309516 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, onabotulinumtoxina, 1 unit (HCPCS:J0585)
• Automated urinalysis test (HCPCS:81003)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Detection test by nucleic acid for organism, quantification (HCPCS:87799)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Insertion of implant in urethra within prostate gland using an endoscope, each additional implant (HCPCS:52442)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Simple bladder irrigation and/or instillation (HCPCS:51700)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for strep (streptococcus, group a), quantification (HCPCS:87652)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Insertion of implant in urethra within prostate gland using an endoscope, 1 implant (HCPCS:52441)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), quantification (HCPCS:87592)
• Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
• Detection test by nucleic acid for chlamydia trachomatis, quantification (HCPCS:87492)
• Detection test for gardnerella vaginalis (bacteria), quantification (HCPCS:87512)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Assessment of muscle signal of pelvic nerves (HCPCS:51792)
• Insertion of device into abdomen with pressure and urine flow rate study (HCPCS:51797)
• Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies (HCPCS:51729)
• Biopsy of prostate gland (HCPCS:55700)
• Imaging of urinary tract following injection of a contrast agent (HCPCS:74420)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope (HCPCS:52310)
• Crushing of stone of ureter with insertion of stent using an endoscope (HCPCS:52356)
• Exam with injections of chemical for destruction of bladder using an endoscope (HCPCS:52287)
• Unclassified drugs (HCPCS:J3490)
• Shock wave crushing of kidney stones (HCPCS:50590)
• Placement of hormone pellet under skin (HCPCS:11980)
• Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope (HCPCS:52601)
• Repair of vaginal defect using an endoscope (HCPCS:57423)
• Surgical repair of vaginal defect using an endoscope (HCPCS:57425)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 1/5/2006 and was last updated on 3/9/2012.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.